New ultrasound could spare patients unnecessary pancreatic surgery
NCT ID NCT07657884
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a new ultrasound technique called SMI can accurately identify benign pancreatic cysts (serous cystadenomas). Currently, many patients with these harmless cysts undergo unnecessary surgery due to diagnostic uncertainty. The study will enroll 60 patients and compare SMI results with the current gold-standard test. If SMI works well, it could provide a safer, cheaper, and non-invasive way to diagnose these cysts.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SMI (Superb Vascular Imaging) ultrasound
- What this could lead to
- If successful, SMI could become a safe, non-invasive way to diagnose benign pancreatic cysts, avoiding risky surgeries.
- What could go wrong
- This is a small, early-stage study with no published data yet. SMI may not be accurate enough to replace current methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CYST OF UNKNOWN ORIGIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Privé Jean Mermoz
RECRUITINGLyon, 69008, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.